Another member, ITIH4, has been demonstrated as a potential diagnostic marker in hepatocellular carcinoma (HCC) that was even superior to AFP; it exhibited a strikingly lower concentration in HCC than normal controls and its expression level was declining during the progression of HCC [9]. This evidence concerns the gene ITIH4 and hepatocellular carcinoma.